FI20012242A0 - Uudet farmaseuttiset yhdisteet - Google Patents

Uudet farmaseuttiset yhdisteet

Info

Publication number
FI20012242A0
FI20012242A0 FI20012242A FI20012242A FI20012242A0 FI 20012242 A0 FI20012242 A0 FI 20012242A0 FI 20012242 A FI20012242 A FI 20012242A FI 20012242 A FI20012242 A FI 20012242A FI 20012242 A0 FI20012242 A0 FI 20012242A0
Authority
FI
Finland
Prior art keywords
pharmaceutical compounds
new pharmaceutical
new
compounds
pharmaceutical
Prior art date
Application number
FI20012242A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Tomi Jaervinen
Jukka Leppaenen
Juhani Huuskonen
Tapio Nevalainen
Jouko Savolainen
Jukka Gynther
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20012242A priority Critical patent/FI20012242A0/fi
Publication of FI20012242A0 publication Critical patent/FI20012242A0/fi
Priority to AU2002342940A priority patent/AU2002342940A1/en
Priority to JP2003545612A priority patent/JP2005509673A/ja
Priority to CA002467166A priority patent/CA2467166A1/fr
Priority to EP02779592A priority patent/EP1453793A2/fr
Priority to PCT/FI2002/000915 priority patent/WO2003043974A2/fr
Priority to US10/495,919 priority patent/US20050059608A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/54—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20012242A 2001-11-19 2001-11-19 Uudet farmaseuttiset yhdisteet FI20012242A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20012242A FI20012242A0 (fi) 2001-11-19 2001-11-19 Uudet farmaseuttiset yhdisteet
AU2002342940A AU2002342940A1 (en) 2001-11-19 2002-11-18 New pharmaceutical compounds
JP2003545612A JP2005509673A (ja) 2001-11-19 2002-11-18 新規な医薬化合物
CA002467166A CA2467166A1 (fr) 2001-11-19 2002-11-18 Nouveaux composes pharmaceutiques
EP02779592A EP1453793A2 (fr) 2001-11-19 2002-11-18 Nouveaux composes pharmaceutiques
PCT/FI2002/000915 WO2003043974A2 (fr) 2001-11-19 2002-11-18 Nouveaux composes pharmaceutiques
US10/495,919 US20050059608A1 (en) 2001-11-19 2002-11-18 Pharmaceutical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20012242A FI20012242A0 (fi) 2001-11-19 2001-11-19 Uudet farmaseuttiset yhdisteet

Publications (1)

Publication Number Publication Date
FI20012242A0 true FI20012242A0 (fi) 2001-11-19

Family

ID=8562282

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20012242A FI20012242A0 (fi) 2001-11-19 2001-11-19 Uudet farmaseuttiset yhdisteet

Country Status (7)

Country Link
US (1) US20050059608A1 (fr)
EP (1) EP1453793A2 (fr)
JP (1) JP2005509673A (fr)
AU (1) AU2002342940A1 (fr)
CA (1) CA2467166A1 (fr)
FI (1) FI20012242A0 (fr)
WO (1) WO2003043974A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040094677A (ko) 2002-01-29 2004-11-10 와이어쓰 코넥신 헤미채널 조절을 위한 조성물 및 방법
DE102005022276A1 (de) * 2005-05-13 2006-11-16 Ellneuroxx Ltd. Derivate von Dihydroxyphenylalanin
JP5210637B2 (ja) * 2005-11-29 2013-06-12 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175069B1 (da) * 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US5236952A (en) * 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
GB9510481D0 (en) * 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives
US5686423A (en) * 1996-02-16 1997-11-11 Department Of Health, The Executive Yuan, Republic Of China Di-and tri-peptide mimetic compounds for Parkinson's disease
GB2321190B (en) * 1997-01-16 2000-09-20 Britannia Pharmaceuticals Ltd Pharmaceutical composition
GB2344819A (en) * 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
WO2002028882A1 (fr) * 2000-10-06 2002-04-11 Xenoport, Inc. Promedicaments d'acides biliaires de l-dopa et utilisation de ces derniers dans le traitement a long terme du parkinsonisme

Also Published As

Publication number Publication date
AU2002342940A1 (en) 2003-06-10
AU2002342940A8 (en) 2003-06-10
JP2005509673A (ja) 2005-04-14
EP1453793A2 (fr) 2004-09-08
WO2003043974A2 (fr) 2003-05-30
WO2003043974A3 (fr) 2003-07-17
CA2467166A1 (fr) 2003-05-30
US20050059608A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
IS6971A (is) Ný efnasambönd
EE200300416A (et) Ravimvorm
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20033205L (no) Terapeutiske kromanforbindelser
DE50209245D1 (de) Neuroprotektives medikament
FI20022128A (fi) Farmaseuttinen koostumus
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
EE200300378A (et) Farmatseutiline kompositsioon
SE0102823D0 (sv) New drug
SE0103116D0 (sv) Pharmaceutical combination
SE0102386D0 (sv) New compounds
SE0100629D0 (sv) New compounds
SE0103461D0 (sv) New compounds
SE0103437D0 (sv) New compounds
SE0102056D0 (sv) New Compounds
SE0104366D0 (sv) New compounds
SE0101958D0 (sv) New compounds
SE0101660D0 (sv) New compounds
SE0104342D0 (sv) New compounds
SE0101659D0 (sv) New compounds
SE0100272D0 (sv) New compounds
FI5468U1 (fi) Farmaseuttinen koostumus
SE0100007D0 (sv) Therapeutic compounds
SE0100006D0 (sv) Therapeutic compounds